Thierry Delozier - Francois Baclesse Canc Ctr

基本信息

浏览量：55

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 138 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer

A. Dezellus,P. Barriere,M. Campone, C. Lemanski,L. Vanlemmens,L. Mignot,T. Delozier,C. Levy,C. Bendavid,M. Debled,T. Bachelot,C. Jouannaud,C. Loustalot,M.A. Mouret-Reynier, A. Gallais-Umbert,D. Masson,T. Freour

European Journal of Cancer（2017）

引用64浏览0WOS引用

Long-Term Follow-Up of the Intergroup Exemestane Study

J. M. Bliss,L. S. Kilburn,R. E. Coleman,J. F. Forbes,A. S. Coates,S. E. Jones,J. Jassem,T. Delozier,J. Andersen,R. J. Paridaens,R. C. Coombes

Journal of Clinical Oncologyno. 22 (2017): 2507-2514

引用19浏览0WOS引用

P1-14-02: Correlation of Circulating Tumor Cells (CTC) and Circulating Endothelial Cells (CEC) with Pathological Complete Response (pCR) during Neoadjuvant Chemotherapy (CT) Combined with Bevacizumab in HER2 Negative Inflammatory Breast Cancer (IBC): Ancillary Study of Phase II Trial BEVERLY 1

Patrice Viens,T Petit,F Dalenc,T Delozier,G Romieu,J Bonneterre,Jm Ferrero,Jy Pierga,Fc Bidard,Fabrice Andre,Pierre Kerbrat,J Lemonnier

Cancer Research（2014）

引用23浏览0引用

Abstract P6-12-08: Serum Biomarkers Identification Using Quantitative Proteomics in Patients with HER2-positive Inflammatory Breast Cancer Receiving Trastuzumab Plus Bevacizumab-Based Chemotherapy (BEVERLY 2 Trial)

A Gonçalves,L Camoin,J-Y Pierga,T Petit,T Delozier,J-M Ferrero,M Campone,J Gligorov,F Lerebours,H Roché,T Bachelot,E Charafe-Jauffret,I Ben Younes,J-P Borg,P Viens

Cancer research（2013）

引用0浏览0引用

Serum Biomarkers Identification Using Quantitative Proteomics In Patients With Her2-Positive Inflammatory Breast Cancer Receiving Trastuzumab Plus Bevacizumab-Based Chemotherapy (Beverly 2 Trial)

A Goncalves,L Camoin,Jy Pierga,T Petit,T Delozier,Jm Ferrero,M Campone,Joseph Gligorov,Florence Lerebours,H Roche,T Bachelot,Emmanuelle Charafejauffret,I Ben Younes,Jp Borg,Patrice Viens

CANCER RESEARCH（2013）

引用0浏览0引用

EMBRACE (Eisai Metastatic Breast Cancer Study Assessing Physician’s Choice Versus E7389) investigators. Eribulin monotherapy versus treatment of physician’s choice in patients …

J Cortes,J O’shaughnessy,D Loesch,JL Blum,LT Vahdat,K Petrakova,P Chollet, A Manikas,V Diéras,T Delozier, V Vladimirov,F Cardoso, H Koh,P Bougnoux, CE Dutcus,S Seegobin, D Mir,N Meneses,J Wanders,C Twelves

Lancetno. 9769 (2011): 914-923

引用96浏览0引用

One-Year Longitudinal Study of Fatigue, Cognitive Functions, and Quality of Life After Adjuvant Radi

S Noal,Christelle Levy,Agnes Hardouin,C Rieux,Natacha Heutte,Carine Segura,Fabienne Collet,Djelila Allouache,O Switsers,C Delcambre,T Delozier,M Henryamar,Florence Joly

Fuel and Energy Abstracts（2011）

引用23浏览0引用

Le cancer du sein sans envahissement ganglionnaire. Au-delà des consensus internationaux: une approche pragmatique [Node negative breast cancer. Beyond international consensus: a pragmatic approach]

F Penaultllorca,D Coeffic,T Delozier,N Dohollou,Gilles Freyer,Joseph Gligorov,A C Hardybessard,William Jacot,J L Misset,J M Nabholtz,T Petit,M Spielmann,M Namer

mag（2011）

引用23浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn